Medicare Enrolled
Dr. Mitchell Folbe, MD
Hematology & Oncology · Troy, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Folbe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Folbe?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Folbe
Dr. Mitchell Folbe is a hematology & oncology specialist in Troy, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Folbe performed 28,078 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Folbe received a total of $33,884 from 84 pharmaceutical and/or device companies across 1498 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Folbe is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 16% volume in MI
$33,884 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗28,078
Medicare services
Top 16% in MI for hematology & oncology
Not available
Unique patients (not deduplicated)
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
15,300 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 8,600 | $43 | $75 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,226 | $0 | $10 |
| Anti-nausea injection (Aloxi/palonosetron) | 730 | $1 | $40 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
641 | $98 | $165 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
207 | $101 | $285 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
175 | $8 | $11 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
148 | $63 | $108 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
145 | $12 | $35 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
125 | $23 | $61 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
113 | $11 | $29 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
104 | $126 | $233 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
99 | $1 | $3 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
78 | $49 | $140 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
74 | $10 | $28 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
67 | $137 | $279 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
62 | $51 | $135 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
60 | $1 | $15 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
40 | $18 | $51 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
36 | $136 | $212 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
28 | $14 | $55 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $101 | $193 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
56.4% high complexity
38.9% medium
4.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$33,884
Total received (2018-2024)
Avg $4,841/year across 7 years
Top 7% in MI for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
1,498
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,179
2023
$4,282
2022
$3,688
2021
$5,652
2020
$3,280
2019
$6,331
2018
$7,470
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$290
Novartis Pharmaceuticals Corporation
$217
Merck Sharp & Dohme LLC
$180
Lilly USA, LLC
$179
Genentech USA, Inc.
$173
Eisai Inc.
$158
Janssen Biotech, Inc.
$157
PFIZER INC.
$136
Celgene Corporation
$135
Incyte Corporation
$116
SOBI, INC
$107
GlaxoSmithKline, LLC.
$103
E.R. Squibb & Sons, L.L.C.
$96
ABBVIE INC.
$93
Daiichi Sankyo Inc.
$86
Coherus Biosciences Inc.
$80
TerSera Therapeutics LLC
$74
Karyopharm Therapeutics Inc.
$70
BeiGene USA, Inc.
$68
Pharmacosmos Therapeutics Inc.
$67
Regeneron Healthcare Solutions, Inc.
$64
Stemline Therapeutics Inc.
$59
Alexion Pharmaceuticals, Inc.
$57
Myriad Genetic Laboratories, Inc.
$55
PharmaEssentia USA Corporation
$54
Genmab U.S., Inc.
$50
ARRAY BIOPHARMA INC
$47
Ipsen Biopharmaceuticals, Inc
$42
TAIHO ONCOLOGY, INC.
$26
Legend Biotech USA Inc.
$21
Acrotech Biopharma Inc.
$20
Gilead Sciences, Inc.
$19
Janssen Pharmaceuticals, Inc
$19
Kite Pharma, Inc.
$17
GENZYME CORPORATION
$16
Exelixis Inc.
$15
Aveo Pharmaceuticals, Inc.
$14
Top 3 companies account for 21.6% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$3,876
PFIZER INC.
$3,338
AstraZeneca Pharmaceuticals LP
$2,388
Novartis Pharmaceuticals Corporation
$2,041
Amgen Inc.
$1,915
Janssen Biotech, Inc.
$1,569
E.R. Squibb & Sons, L.L.C.
$1,220
Celgene Corporation
$1,216
Secura Bio, Inc.
$1,200
GENZYME CORPORATION
$925
Incyte Corporation
$902
Lilly USA, LLC
$794
Coherus Biosciences Inc.
$764
Merck Sharp & Dohme Corporation
$692
Exelixis Inc.
$684
Eisai Inc.
$633
Merck Sharp & Dohme LLC
$509
Seagen Inc.
$490
Takeda Pharmaceuticals U.S.A., Inc.
$471
ASD SPECIALTY HEALTHCARE, LLC
$421
ABBVIE INC.
$368
Kite Pharma, Inc.
$342
Alexion Pharmaceuticals, Inc.
$338
Daiichi Sankyo Inc.
$331
Ipsen Biopharmaceuticals, Inc
$290
Dova Pharmaceuticals
$283
Karyopharm Therapeutics Inc.
$273
GlaxoSmithKline, LLC.
$244
BeiGene USA, Inc.
$227
JAZZ PHARMACEUTICALS INC.
$224
AbbVie Inc.
$204
Pharmacyclics LLC, An AbbVie Company
$201
SOBI, INC
$199
Gilead Sciences, Inc.
$196
Taiho Oncology, Inc.
$185
AMAG Pharmaceuticals, Inc.
$173
ASD Specialty Healthcare, LLC
$171
Janssen Pharmaceuticals, Inc
$166
Puma Biotechnology, Inc.
$161
Cardinal Health 108, LLC
$156
Astellas Pharma US Inc
$156
Regeneron Healthcare Solutions, Inc.
$143
Myriad Genetic Laboratories, Inc.
$136
Foundation Medicine, Inc.
$132
Focal Therapeutics, Inc.
$129
Verastem, Inc.
$129
EISAI INC.
$128
Stemline Therapeutics Inc.
$124
SANOFI-AVENTIS U.S. LLC
$120
Deciphera Pharmaceuticals Inc.
$120
Mirati Therapeutics, Inc.
$117
ARRAY BIOPHARMA INC
$113
Bayer HealthCare Pharmaceuticals Inc.
$104
Teva Pharmaceuticals USA, Inc.
$100
Spectrum Pharmaceuticals Inc.
$86
EMD Serono, Inc.
$82
Pharmacosmos Therapeutics Inc.
$80
ADC Therapeutics America, Inc.
$79
SERVIER PHARMACEUTICALS LLC
$78
TESARO, Inc.
$75
TerSera Therapeutics LLC
$74
Mylan Institutional Inc.
$67
Epizyme, Inc.,
$64
MorphoSys, US Inc.
$62
TAIHO ONCOLOGY, INC.
$57
PharmaEssentia USA Corporation
$54
Genmab U.S., Inc.
$50
Sobi, Inc
$44
Rigel Pharmaceuticals, Inc.
$44
Jazz Pharmaceuticals Inc.
$37
AbbVie, Inc.
$36
Servier Pharmaceuticals LLC
$36
RECORDATI_RARE_DISEASES_INC.
$28
Aveo Pharmaceuticals, Inc.
$26
INSYS Therapeutics Inc
$26
Helsinn Therapeutics (U.S.), Inc.
$25
Acrotech Biopharma LLC
$23
Legend Biotech USA Inc.
$21
Acrotech Biopharma Inc.
$20
AVEO Pharmaceuticals, Inc.
$19
Sumitomo Pharma America, Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$16
Innate Pharma, Inc
$13
Pharmacyclics LLC, an AbbVie Company
$12
Top 3 companies account for 28.3% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · AFINITOR · AKYNZEO · ALIMTA · AUGTYRO · Abraxane · Alecensa · Aliqopa · Avastin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · BioZorb · Blincyto · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELZONRIS · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Enhertu · Epkinly · Erleada · FARYDAK · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · Fulphila · GAZYVA · GLEEVEC · HEMADY · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · INVOKANA · Imbruvica · Inrebic · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lumoxiti · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCREVUS · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PRECISETUMOR · PROMACTA · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETACRIT · RETEVMO · ROLVEDON · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYNAGIS · SYNDROS · Somatuline Depot · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vanflyta · Vectibix · Venclexta · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xofigo · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYKADIA · ZYTIGA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
121
County median income
$95,296
Nearest hospital to ZIP centroid (approximate)
BEAUMONT HOSPITAL, TROY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Folbe is a mixed practice specialist, with above-average Medicare volume (top 16% in MI), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Folbe experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Folbe performed 15,300 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Folbe receive payments from pharmaceutical companies?
Yes. Dr. Folbe received a total of $33,884 from 84 companies across 1,498 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Folbe's costs compare to other hematology & oncology specialists in Troy?
Dr. Folbe's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Folbe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Troy
Browse hematology & oncology specialists in Troy ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MI
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MI
Which MI hematology & oncology specialists receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology